Expression of prostanoid receptors in human ductus arteriosus.
1. Prostaglandins play a major role in maintaining ductal patency in utero. Ductal tone is regulated by both locally released and circulating vasodilatory prostaglandins. In infants with ductus arteriosus-dependent congenital heart disease, ductal patency is maintained by intravenous administration of prostaglandin (PG) E(1). Little information is available regarding the expression of prostaglandin receptors in man. 2. By means of RT-PCR and immunohistochemistry we studied the expression of the PGI(2) receptor (IP), the four different PGE(2) receptors (EP1, EP2, EP3 and EP4), and the receptors for thromboxane (Tx) A(2) (TP), PGD(2) (DP) and PGF(2alpha) (FP) in the ductus arteriosus of three newborn infants with ductus arteriosus-dependent congenital heart disease and intravenous infusion of PGE(1) and of one 8 month old child with a patent ductus arteriosus. 3. The EP3, EP4, FP, IP and TP receptor were markedly expressed at the mRNA and protein level, whereas the EP2 receptor was weakly expressed and the EP1 receptor was detected in two out of four tissue specimens only. The DP receptor was not detected in any of the samples. The most pronounced expression, which was located in the media of the ductus arteriosus, was observed for the EP4 and TP receptors followed by IP and FP receptor protein. 4. These data indicate that ductal patency during the infusion of PGE(1) in infants with ductus arteriosus-dependent congenital heart disease might be mediated by the EP4 and IP receptor. The data further suggest that a heterogeneous population of prostanoid receptors may contribute to the regulation of ductus arteriosus tone in humans.
Leonhardt
Andreas
A
Department of Pediatrics, Philipp's University, 35033 Marburg, Germany.
Glaser
Alexander
A
Wegmann
Markus
M
Schranz
Dietmar
D
Seyberth
Hannsjörg
H
Nüsing
Rolf
R
D000527:Alprostadil / Q000494:pharmacology / Q000627:therapeutic use; D004373:Ductus Arteriosus / Q000187:drug effects / Q000378:metabolism*; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D011982:Receptors, Prostaglandin / Q000096:biosynthesis* / Q000235:genetics
D011982:Receptors, Prostaglandin; D000527:Alprostadil